Fingerprint Dive into the research topics where Istituto Scienze Neurologiche is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Epilepsy Medicine & Life Sciences
Seizures Medicine & Life Sciences
Sleep Medicine & Life Sciences
Mutation Medicine & Life Sciences
Electroencephalography Medicine & Life Sciences
Leber's Hereditary Optic Atrophy Medicine & Life Sciences
Narcolepsy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2018

Research Output 1969 2019

A multicenter randomized controlled trial on the upper limb robotic rehabilitation in subacute stroke using a set of robotic and sensor-based devices: Feasibility of the InTeReSt study

The FDG Robotic Rehabilitation Group, Aprile, I., Germanotta, M., Cruciani, A., Loreti, S., Pecchioli, C., Montesano, A., Galeri, S., Cecchi, F., Diverio, M., Falsini, C., Speranza, G., Langone, E. & Padua, L., Jan 1 2019, Biosystems and Biorobotics. Springer International Publishing AG, p. 508-512 5 p. (Biosystems and Biorobotics; vol. 21).

Research output: Chapter in Book/Report/Conference proceedingChapter

Patient rehabilitation
Robotics
Sensors
Health

A national mandatory-split liver policy: A report from the Italian experience

Angelico, R., Trapani, S., Spada, M., Colledan, M., de Ville de Goyet, J., Salizzoni, M., De Carlis, L., Andorno, E., Gruttadauria, S., Ettorre, G. M., Cescon, M., Rossi, G., Risaliti, A., Tisone, G., Tedeschi, U., Vivarelli, M., Agnes, S., De Simone, P., Lupo, L. G., Di Benedetto, F. & 11 others, Santaniello, W., Zamboni, F., Mazzaferro, V., Rossi, M., Puoti, F., Camagni, S., Grimaldi, C., Gringeri, E., Rizzato, L., Nanni Costa, A. & Cillo, U., 2019, In : American Journal of Transplantation. 19, 7, p. 2029-2043

Research output: Contribution to journalArticle

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial

Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, Tortora, G., Bonetti, A., Spallanzani, A., Frassineti, G. L., Tassinari, D., Giuliani, F., Cinieri, S., Maiello, E., Verusio, C., Bracarda, S., Catalano, V., Basso, M., Ciuffreda, L., De Vita, F., Parra, H. S., Fornaro, L., Caporale, M., De Braud, F. & Pietrantonio, F., Mar 29 2019, In : BMC Cancer. 19, 1, 283.

Research output: Contribution to journalArticle

Esophagogastric Junction
Paclitaxel
Stomach
Maintenance
Drug Therapy